Market Place
Sourcing Support
J&J Reduces Sirturo Price In South Africa, Ending Antitrust Probe
09 Jul 2024 //
FIERCE PHARMA
J&J`s tuberculosis Sirturo lands full US, EU approvals
08 Jul 2024 //
FIERCE PHARMA
Janssen Submits Phase 3 Study Data to the EMA and FDA for SIRTURO
07 Nov 2023 //
PRESS RELEASE
After pubic pressure, J&J says it won`t enforce Sirturo patents
02 Oct 2023 //
FIERCE PHARMA
J&J, Lupin reduce price of TB drug bedaquiline in poor countries
01 Sep 2023 //
FIERCE PHARMA
J&J loses attempt to extend patent in India for tuberculosis drug
23 Mar 2023 //
ENDPTS
Johnson & Johnson tuberculosis drug`s final patent hearing set for today
17 Jan 2023 //
ECONOMIC TIMES
Diabetes, patented TB, HIV drugs enter essential list
13 Sep 2022 //
ECONOMICTIMES
Ayahuasca inspires another biotech startup ATAI; Mylan TB drug gets green light
22 Jul 2020 //
ENDPTS
Johnson & Johnson cuts price of TB drug bedaquiline in poorer countries
07 Jul 2020 //
REUTERS
U.S. FDA Approves New Pediatric Formulation of SIRTURO® (bedaquiline)
27 May 2020 //
PRESS RELEASE
New TB drug regimen controls resistant disease in 9 of 10 cases: study
06 Mar 2020 //
REUTETRS
J&J commits $500M investment to end TB, HIV
07 Oct 2019 //
BIOSPECTRUM ASIA
FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis
14 Aug 2019 //
PR NEWSWIRE
J&J`s Tuberculosis Drug Gets FDA Nod for Adolescent Patients
12 Aug 2019 //
NASDAQ
FDA advisory panel recommends approval of TB Alliance`s tuberculosis treatment
08 Jun 2019 //
REUTERS
J&J doubles bedaquiline donation in India to 20,000 courses
12 Apr 2019 //
PHARMABIZ
PvPI releases list of 9 drugs with previously unknown AEs; list
27 Mar 2019 //
PHARMABIZ
Delamanid, Bedaquiline-based therapy to be boosted to tackle MDR TB
08 Feb 2019 //
PHARMA BIZ
The Bedaquiline conundrum: Why this TB drug is creating an intense debate
06 Jan 2019 //
MONEY CONTROL
JNMC to provide wonder drug Bedaquiline free to TB patients
27 Dec 2018 //
Johnson and Johnson asked to cut down price of new TB drug
23 Oct 2018 //
ECONOMIC TIMES
The bedaquiline boost
03 Sep 2018 //
THE HINDU
Price of J&J’s TB drug to drop by more than half
21 Aug 2018 //
ECONOMIC TIMES
WHO announces landmark changes in MDR-TB treatment regimens
20 Aug 2018 //
ECONOMIC TIMES
Johnson and Johnson to offer first TB drug in 40 years for $900
22 Jul 2018 //
ECONOMIC TIMES
J&J, Macleods in talks for licence deal of tuberculosis drug
12 Mar 2018 //
ECONOMIC TIMES
WHO invites applications from drug companies pre-qualification of MDR TB drugs
09 Mar 2018 //
ECONOMIC TIMES
J&J Partners with India`s IMTECH to Develop New Treatments for TB
17 Aug 2017 //
GENENG NEWS
Drug to treat MDRTB to be made available across the country
12 Apr 2017 //
ECONOMIC TIMES
Health groups call on central govt to urgently make delamanid available in India
31 Jan 2017 //
PHARMABIZ
Battle for access to tuberculosis medicine reaches HC
03 Jan 2017 //
ECONOMIC TIMES
Health Ministry Dragged to Court Over Curbs on TB Drugs
03 Jan 2017 //
ECONOMIC TIMES
New lifesaving drugs too expensive for most drug-resistant TB patients: MSF
21 Mar 2016 //
REUTERS
‘Miracle drug’ for resistant Tuberculosis to be rolled out for trial today
21 Mar 2016 //
ECONOMIC TIMES
First TB drug in 40 years will begin trial run
20 Nov 2015 //
MUMBAI MIRROR
Dishman gets licence from Johnson & Johnson to produce TB drug raw material
23 Sep 2015 //
THE ECONOMIC TIMES
Exporting to Brazil? ANVISA is tough and hands-on, says Kemwell
10 Jun 2015 //
IN PHARMA TECHNOLOGIST
